# Stage 2 normal cycle — 2026-09-14

Run `f69753d6-76b4-4255-b370-bdb39af6070f`; decision time 2026-09-14 Europe/Amsterdam. Alpaca clock: New York date 2026-09-14, regular market open, timestamp 12:33:43 ET at final reconciliation. Safety gate passed: `ALPACA_PAPER_TRADE=true`, paper endpoint exact.

## Artifact gate and discovery

`data/daily_shortlist_state.json` completed successfully for 2026-09-14 at 10:18:32 ET. `stage1_screen.json` had 192 candidates and completed-bar/as-of date 2026-09-11. `stage1_experts.json` had 19 candidates, generated 2026-09-14T14:07:00Z. `stage1_shortlist.md` matched the screen date and expert timestamp and contained community, expert and technical sections. The enriched build covered all 40 unique tickers and matched shortlist hash `6597460e...d864a5c`; Yahoo was 8 ok / 32 partial, technical was 35 ok / 1 stale / 2 partial / 2 missing. Partial Yahoo fields were preserved as unknown after one permitted retry plus the user-requested follow-up retry.

## Pre-action broker state and risk posture

Account was ACTIVE and unblocked: equity $101,487.97, cash $85,921.43, long stock market value $15,571.54, buying power $367,644.02, options buying power $73,582.06. Positions were HOOD 30, MMED 125, MU 6, RBLX 75, and the COO Sep. 18 $55/$50 put spread. META had the only pre-existing open parent order: 30-share GTC buy at $644 with held $678 target / $634.50 stop. Risk posture was selective aggressive with moderate caution: no material breach, no minimum cash floor, but avoid compounding MU/electronics correlation, MMED gap/supply risk, COO illiquidity/expiry, and stale/wide quote risk.

## Research funnel and coverage ledger

Research advanced: AVT fundamental, ARW fundamental, ESI fundamental, IREN fundamental plus a focused indicative call-chain check, MU technical management review, and RBLX technical management review. Successful research artifacts: `memory/research/2026-09-14/182416-AVT-fundamental.md`, `182455-ARW-fundamental.md`, `182522-ESI-fundamental.md`, `182557-IREN-fundamental.md`, `182650-MU-technical.md`, `182721-RBLX-technical.md`. IREN chain covered Sep. 25–Oct. 16 calls, strikes $35–$60: IV was roughly 82%–95%, so no option order was selected despite the defined-risk path being examined.

Coverage in shortlist order, one disposition per unique ticker:

- `META` manage/hold existing $644 GTC bracket; `SPY` reject broad-beta duplicate; `DTE` reject bearish/no actionable long catalyst; `MU` manage/research hold; `GOOG` watch, no differentiated catalyst; `QQQ` reject broad-beta duplicate; `GOOGL` watch, duplicate and weak short-term tape; `NVDA` watch, semiconductor overlap and -4.5% 5-day tape; `AGI` watch, -4.7% 5-day and negative EPS revision; `ATAI` insufficient_evidence, stale technical/quote and missing fields.
- `BLSH` reject, 54x forward P/E, -42% EPS revision and target only about +2%; `CAPR` insufficient_evidence, binary biotech/partial technical and -9.6% 5-day move after a +98% 20-day move; `COIN` watch, -9% 5-day, 69x P/E and only about +5% target upside; `IREN` research/no trade, high-beta negative-profitability and dilution risk despite upgrade; `SPRO` insufficient_evidence, missing technical and most fields; `CIZN` insufficient_evidence, missing technical and stale 2023 quote; `GEV` watch, fresh target but -8.8% 20-day and 34.6x P/E; `ESI` research/selected buy order; `IP` watch, target cut and -16.5% 20-day; `ATO` reject long stock, downgrade not sufficient for a researched put trade.
- `COO` manage existing put spread/no add; `NAVN` reject, -24% 5-day/-29% 20-day breakdown without catalyst; `TTAN` reject, -41% 20-day bearish breakdown; `TENB` reject, -25% 20-day with only about +3% target upside; `ARW` research/watch conditional, value/revision setup but same distributor correlation and stabilization needed; `VTIP` reject ETF anomaly; `HDB` watch, high-volume non-directional setup; `OKLO` reject/watch, negative earnings and bearish technical; `GT` reject/watch, bearish breakdown and negative revisions; `MUB` reject ETF anomaly; `HPE` watch, strong recent move but no confirmed earnings timing; `TRP` reject/watch, bearish breakout; `AVT` research/watch conditional, strong value/revision setup but do not stack with ESI; `LULU` reject/watch, -17% 20-day and -59% EPS revision; `ACVA` reject/watch, +55% 5-day chase risk and partial technical; `ACWX` reject ETF anomaly; `DAMD` insufficient_evidence, extreme local return anomaly and missing fundamentals; `STIP` reject ETF; `EXR` watch, -7.8% 20-day without catalyst; `VTEB` reject ETF anomaly.

## Decisions and execution

- RBLX investment decision: trim 25 of 75 into overbought gap-fill resistance; stock order submitted as day limit sell at $50.50, then confirmed `filled` 25/25 at $50.50. Broker order `76114a4e-bd9f-486b-95e9-ea3582305a9b`, filled 16:30:51Z. Position is 50 shares; ghost definition is `memory/ghost-trades/2026-09-14/alpaca-stage2-20260914-RBLX-sell.md`.
- ESI investment decision: tactical 75-share buy within $31.80–$32.30, sized for about $132 to $30.40 daily-close invalidation. Day limit buy at $32.16 submitted as `3b2caccb-8451-473f-ab70-f955bbccd657`, final status `new`, 0/75; no replacement or chase. Ghost definition is `memory/ghost-trades/2026-09-14/alpaca-stage2-20260914-ESI-buy.md`.
- Existing positions: HOOD HOLD; MMED HOLD pending daily-close rule; MU HOLD/no add with updated $894/$880 reviews; COO HOLD defined-risk spread; META HOLD existing conditional bracket because current IEX quote $659.32/$662.12 is above the $644 entry. No other order action.

Execution used MCP only. Delayed-SIP inputs were about 15 minutes delayed and labeled; current IEX spot checks were positive except an unusually wide HOOD market. No SIP, live endpoint, direct REST/CLI fallback, or assumed fill was used. Post-action final Alpaca state: equity $101,537.72, cash $87,183.93, long stock market value $14,358.79, buying power $366,886.31, options buying power $72,400.93. Open parents: ESI new 0/75 and META new 0/30.

## Memory and handoff

Updated portfolio state, ticker plans, RBLX/MU/ESI histories, and two new ghost definitions before publication. No lesson update was made; active lessons applied were bounded/idempotent execution, daily-close invalidation, overlap mapping, target activation, and timing-limited provenance. Handoff will be published after checkpoint validation with both ghost files attached. Dashboard sync is a post-publication reporting step.

<!-- run-checkpoint: 2026-09-14T18:40:44+02:00 -->

## Stage 2 review and cash deployment — 2026-09-14T19:05:38+02:00

Run `17d021b8-789f-4ec1-8bd1-4b659fda4b56`. Normal cycle requested immediately after the prior session to review its decisions and deploy excess cash. Safety gate passed with the exact paper endpoint. Alpaca regular market remained open; final full reconciliation used the 13:03:37 ET account snapshot plus later ESI order/quote validation through 13:05:26 ET.

### Review of the just-finished session

Broker evidence confirmed the prior RBLX trim was correct operationally: order `76114a4e-bd9f-486b-95e9-ea3582305a9b` filled 25/25 at $50.50, leaving 50 shares. ESI order `3b2caccb-8451-473f-ab70-f955bbccd657` remained `new`, 0/75 at $32.16, and META remained `new`, 0/30 at $644 with held $678 target and $634.50 stop. The earlier risk work and ticker management were sound, but rejecting SPY merely as a broad-beta duplicate was not consistent with only about 14% actual long-stock exposure and about 86% cash. Ghost queue status showed the earlier run already in the reviewer pending queue; the portfolio text saying publication was pending was a stale label, not an incomplete broker action.

### Artifact gate, coverage, and research funnel

The shortlist remained as of 2026-09-11 with 40 unique tickers. A new enriched build completed at `2026-09-14T16:50:56.954831+00:00`, matched shortlist hash `6597460e...d864a5c`, and covered all 40 rows: Yahoo 8 ok / 32 partial; technical 35 ok / 1 stale / 2 partial / 2 missing. The whole table was rescanned. SPY alone advanced for new moneyheap work because the user's cash-deployment objective materially changed its portfolio role; the earlier same-session research already resolved the leading single-stock questions, and more distributor/high-beta work was unlikely to change the ranking before the Fed event.

Coverage in shortlist order, exactly one disposition per ticker:

- `META` manage/hold $644 bracket; `SPY` research/selected starter buy; `DTE` reject long on bearish tape and no differentiated catalyst; `MU` manage/hold no add; `GOOG` watch without a short-horizon catalyst; `QQQ` watch as more concentrated duplicate of selected SPY; `GOOGL` watch duplicate; `NVDA` watch due MU/SPY technology overlap; `AGI` watch with negative EPS revisions; `ATAI` insufficient_evidence because technical data is stale.
- `BLSH` reject on expensive forward multiple and negative revisions; `CAPR` insufficient_evidence due binary biotech risk and partial technical data; `COIN` watch after weak 5-day tape and high valuation; `IREN` watch/no trade after same-session research found dilution/high-beta risk and expensive options; `SPRO` insufficient_evidence with missing technical data; `CIZN` insufficient_evidence with missing technical data and stale quote provenance; `GEV` watch on valuation and weak 20-day tape; `ESI` manage/hold existing bounded order; `IP` watch after target cut and weak 20-day tape; `ATO` reject long and no put research because a downgrade alone does not establish an investable bearish thesis.
- `COO` manage/hold existing put spread; `NAVN` reject on severe breakdown without catalyst; `TTAN` reject on severe bearish breakdown; `TENB` reject on breakdown and limited target upside; `ARW` watch after same-session research because ESI/MU already create distributor/electronics overlap; `VTIP` reject as non-actionable ETF volume anomaly; `HDB` watch with non-directional setup; `OKLO` reject long on negative earnings and bearish tape, with no sufficiently differentiated bearish catalyst for a new option study; `GT` reject long on bearish breakdown and revisions, with no sufficiently differentiated option edge; `MUB` reject as non-actionable ETF anomaly.
- `HPE` watch after a stretched recent move and uncertain event timing; `TRP` reject/watch on bearish breakout without a catalyst; `AVT` watch after same-session research because stacking it with MU/ESI is not justified; `LULU` reject/watch on weak tape and sharply negative revisions; `ACVA` reject chase after a 55% 5-day move; `ACWX` reject as non-actionable ETF anomaly; `DAMD` insufficient_evidence because the extreme local return anomaly lacks corroborating fundamentals; `STIP` reject as non-actionable ETF setup; `EXR` watch without a catalyst; `VTEB` reject as non-actionable ETF anomaly.

Fresh moneyheap research: [SPY technical](../research/2026-09-14/185624-SPY-technical.md) and [SPY fundamental](../research/2026-09-14/185715-SPY-fundamental.md). Technical evidence found an intact structural bull trend but a low-ADX consolidation near $757–$774; fundamental evidence found elevated valuation, concentration, and Sep. 15–16 FOMC risk. Both favored staged deployment rather than either 86% cash or an immediate full allocation.

### Risk posture and decisions

Posture: staged aggressive with event-aware caution, moderate confidence. Before the new order, equity was $101,549.72, cash $87,183.93, and long stock about 14.1% of equity. The selected 13-share SPY tranche risked about $161 (0.16% of equity) to its $750.50 daily-close invalidation and about $793 (0.78%) in an 8% adverse scenario. After its fill, actual long stock was about 23.9% of equity. If both existing ESI and META entries also fill at their limits, total long stock would be about 45.3% of current equity, inside the research-supported 40%–60% staged exposure range. No minimum cash floor was imposed.

Constraints: no blind second SPY tranche before the Fed event; consider another 13 shares only near $756.50–$759 with a stable thesis-valid market or after a confirmed daily close above $766.50. Review SPY at $774/$779 and on a daily close below $750.50. Do not add MU before its $930 confirmation rule, do not chase ESI or META, and count SPY's technology concentration together with MU, HOOD, META and any ESI fill. Reassess on the Sep. 15–16 FOMC outcome, ESI or META fill, SPY trigger, MMED daily close, and COO expiry.

- SPY stock decision: BUY 13 shares as the first core tranche. Day limit `alpaca-stage2-20260914-SPY-buy` at $762.90 submitted after a $762.76/$762.86 IEX quote and confirmed `filled` 13/13 at $762.89 under broker order `8a92ac2c-5cb4-4128-9b33-855d7f69baac`. Holding period 2–8 weeks; daily-close invalidation $750.50. Ghost definition: [SPY staged entry](../ghost-trades/2026-09-14/alpaca-stage2-20260914-SPY-buy.md).
- SPY option decision: no order. Core stock expresses the intended durable beta without event IV, decay, leverage, or expiry risk.
- ESI stock decision: retain the 75-share $32.16 day limit, 0/75 filled; no chase or replacement. Three post-anomaly IEX checks from 13:03:52–13:05:26 ET remained wide, ranging $31.85–$32.21 bid and $32.23–$33.73 ask. The bounded limit remains inside the researched $31.80–$32.30 entry range and cannot cross the abnormal ask; let it expire if unfilled. ESI option decision: no order because stock size already provides the selected exposure.
- META stock decision: retain the 30-share $644 GTC bracket, 0/30 filled; current IEX quote remained well above entry. META option decision: no order because the stock bracket is the preferred defined plan.
- HOOD stock decision: HOLD 30, no add; option decision no order. MMED: HOLD 125 under the explicit daily-close rule, no add or option. MU: HOLD 6/no add; no overlapping option ahead of earnings. RBLX: HOLD 50-share runner after the confirmed trim; no add or option. COO: HOLD the Sep. 18 $55/$50 put spread; indicative long-put $1.23/$1.63 and short-put $0/$0.03 remained illiquid, so no add, close, roll, exercise or assignment action.

Lessons applied: bounded/idempotent execution, broker reconciliation after the mutation, current-price/event reconciliation, preserved daily-close invalidation, stock/options overlap mapping, and no chase on open limits. Initial moneyheap access failed once under the sandbox and once while the local service was stopped; the local service was started, both requests succeeded and were persisted, then the service was shut down. No broker mutation was retried because of those research transport failures.

### Post-action reconciliation

At 13:03:37 ET Alpaca paper state was ACTIVE and unblocked: equity $101,534.05, cash $77,266.36, long stock market value $24,272.69, buying power $354,946.95, options buying power $72,394.09. Positions were SPY 13, HOOD 30, MMED 125, MU 6, RBLX 50, and the two COO option legs. Open parents were ESI `new` 0/75 and META `new` 0/30 with held bracket legs. No fill was assumed. Memory and the new SPY ghost definition were prepared for handoff.

<!-- run-checkpoint: 2026-09-14T19:05:38+02:00 -->
